Advancing Cancer Treatments: The role of oligonucleotides-based therapies in driving progress
B Dume, E Licarete, M Banciu - Molecular Therapy-Nucleic Acids, 2024 - cell.com
Although recent advancements in cancer immunology have resulted in the approval of
numerous immunotherapies, minimal progress has been observed in addressing hard-to …
numerous immunotherapies, minimal progress has been observed in addressing hard-to …
Binary antisense oligonucleotide agent for cancer marker-dependent degradation of targeted RNA
VS Drozd, AA Eldeeb, DM Kolpashchikov… - nucleic acid …, 2022 - liebertpub.com
Antisense oligonucleotide technology is one of the most successful gene therapy (GT)
approaches. However, low selectivity of antisense agents limits their application as …
approaches. However, low selectivity of antisense agents limits their application as …